Lamotrigine for Absence Seizures

The effectiveness and safety of lamotrigine (Lamictal) monotherapy in newly diagnosed typical absence seizures in 45 children and adolescents, aged 3-15 years, were evaluated in a placebo-controlled, double-blind trial at centers in Norfolk, VA; Akron, OH; Boston, MA; and Research Triangle Park, NC.

Bibliographic Details
Main Author: J Gordon Millichap
Format: Article
Language:English
Published: Pediatric Neurology Briefs Publishers 1999-08-01
Series:Pediatric Neurology Briefs
Subjects:
Online Access:https://www.pediatricneurologybriefs.com/articles/2034
id doaj-07fb5c54aa664ce89f2ed6d6bfade330
record_format Article
spelling doaj-07fb5c54aa664ce89f2ed6d6bfade3302020-11-25T00:15:37ZengPediatric Neurology Briefs PublishersPediatric Neurology Briefs1043-31552166-64821999-08-01138616110.15844/pedneurbriefs-13-8-72021Lamotrigine for Absence SeizuresJ Gordon Millichap0Northwestern University Feinberg School of MedicineThe effectiveness and safety of lamotrigine (Lamictal) monotherapy in newly diagnosed typical absence seizures in 45 children and adolescents, aged 3-15 years, were evaluated in a placebo-controlled, double-blind trial at centers in Norfolk, VA; Akron, OH; Boston, MA; and Research Triangle Park, NC.https://www.pediatricneurologybriefs.com/articles/2034typical absence seizureshyperventilationprotocol analysis
collection DOAJ
language English
format Article
sources DOAJ
author J Gordon Millichap
spellingShingle J Gordon Millichap
Lamotrigine for Absence Seizures
Pediatric Neurology Briefs
typical absence seizures
hyperventilation
protocol analysis
author_facet J Gordon Millichap
author_sort J Gordon Millichap
title Lamotrigine for Absence Seizures
title_short Lamotrigine for Absence Seizures
title_full Lamotrigine for Absence Seizures
title_fullStr Lamotrigine for Absence Seizures
title_full_unstemmed Lamotrigine for Absence Seizures
title_sort lamotrigine for absence seizures
publisher Pediatric Neurology Briefs Publishers
series Pediatric Neurology Briefs
issn 1043-3155
2166-6482
publishDate 1999-08-01
description The effectiveness and safety of lamotrigine (Lamictal) monotherapy in newly diagnosed typical absence seizures in 45 children and adolescents, aged 3-15 years, were evaluated in a placebo-controlled, double-blind trial at centers in Norfolk, VA; Akron, OH; Boston, MA; and Research Triangle Park, NC.
topic typical absence seizures
hyperventilation
protocol analysis
url https://www.pediatricneurologybriefs.com/articles/2034
work_keys_str_mv AT jgordonmillichap lamotrigineforabsenceseizures
_version_ 1725385783264673792